SCHOTT Pharma
Jasko Terzic is a seasoned finance professional specializing in investor relations and equity research, currently serving as Senior Manager Investor Relations at SCHOTT Pharma since October 2022, where responsibilities include establishing an investor relations department and managing IPO activities for a healthcare company with a market cap exceeding 5 billion euros. Previously, Jasko held the position of Senior Investor Relations Manager at Gerresheimer, focusing on ESG initiatives for a mid-cap healthcare firm, and has extensive experience as a Senior Equity Research Analyst at notable institutions including Bankhaus Lampe KG, Bankhaus Metzler, and DZ BANK, concentrating on various sectors such as capital goods, automotive, and consumer goods. Jasko Terzic holds a degree from the CFA Institute, acquired in 2010.
This person is not in any teams
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social